Craft

Jiangsu Hansoh Pharmaceutical Group

Stock Price

$18.2

2024-05-02

Market Capitalization

$107.9 B

2024-05-02

Revenue

¥10.1 B

FY, 2023

Jiangsu Hansoh Pharmaceutical Group Summary

Company Summary

Overview
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company. It is committed to innovation and research in the six therapeutic areas including CNS, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular.
Type
Public
Status
Active
Founded
1995
HQ
Lianyungang Shi, CN | view all locations
Website
http://www.hansoh.cn/
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Lianyungang Shi, Jiangsu Sheng HQ

    China

    Dong Jin Lu & Hua Guo Shan Da Dao, Lianyun Qu

Jiangsu Hansoh Pharmaceutical Group Financials

Summary Financials

Revenue (FY, 2023)
¥10.1B
Gross profit (FY, 2023)
¥9.5B
Net income (FY, 2023)
¥3.3B
Cash (FY, 2023)
¥22.4B
EBIT (FY, 2023)
¥2.7B

Footer menu